ARCHIVES

NCI-Approved Clinical Trials Listed For January

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

Treatment IND or GM-CSF Is Approved

October 5, 1990

GSK HPV Vaccine Offers Protection From 4 HPV Types

April 27, 2007

Young Elected ACS President, Von eschenback Pres.-Elect.

November 9, 2001

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

January 23, 1976